A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity

NCT07665879 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Eloralintide
OTHER: Placebo

Sponsor

Eli Lilly and Company